SCHEMBL24313751

SCHEMBL24313751

CN(C)c1cc(C2CC2)cc2oc(C(=O)NS(=O)(=O)c3ccccc3)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 6/20 0.40
BCAT1 P54687 4/20 0.39
ENPP3 O14638 1/20 0.37
ENPP1 P22413 1/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
PTGS1 P23219 2/20 0.36
PTGS2 P35354 2/20 0.36
BRD4 O60885 1/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314242 0.87 PTGER4 (0.37) PTGER4ALDH1A1GAAKMT2AMEN1
SCHEMBL29587615 0.87 PTGER4 (0.37) PTGER4ALDH1A1GAAKMT2AMEN1
SCHEMBL24313633 0.84 HPGD (0.44) PTGER4BCAT1CA12CA9PTGS1
SCHEMBL29588267 0.82 GAA (0.35) PTGER4ALDH1A1GAAMAPTKMT2A
SCHEMBL24313796 0.82 RBP4 (0.42) PTGER4BCAT1PTGS1PTGS2ALDH1A1
SCHEMBL29587778 0.79 HSD17B10 (0.39) ALDH1A1HTTSMN1; SMN2NPSR1RAB9A
SCHEMBL24314312 0.79 HSD17B10 (0.39) ALDH1A1HTTSMN1; SMN2NPSR1RAB9A
SCHEMBL24313906 0.79 PTGER4 (0.45) PTGER4BCAT1PTGS1PTGS2HPGD
SCHEMBL24313756 0.79 LMNA (0.33) ALDH1A1GAAMAPTHTTSMN1; SMN2
SCHEMBL24313929 0.79 MCL1 (0.38) PTGS1ALDH1A1MAPTKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed